Effective communication of treatment side effects (SE) is critical for shared decision-making (SDM) in localized prostate cancer. We sought to qualitatively characterize how physicians communicate SE in consultations.
We transcribed 50 initial prostate cancer treatment consultations across nine multidisciplinary providers (Urologists, Radiation Oncologists, Medical Oncologists) at our tertiary referral, academic center. Coders identified quotes describing SE and used an inductive approach to establish a hierarchy for granularity of communication: (1) not mentioned, (2) name only, (3) generalization("high"), (4) average incidence without timepoint, (5) average incidence with timepoint, and (6) precision estimate. We reported the most granular mode of communication for each SE throughout the consultation overall and across specialty and tumor risk.
Among consultations discussing surgery (n = 40), erectile dysfunction (ED) and urinary incontinence (UI) were omitted in 15% and 12%, not quantified (name only or generalization) in 47% and 30%, and noted as average incidence without timeline in 8% and 8%, respectively. In only 30% and 49% were ED and UI quantified with timeline (average incidence with timeline or precision estimate), respectively. Among consultations discussing radiation (n = 36), irritative urinary symptoms, ED, and other post-radiotherapy SE were omitted in 22%, 42%, and 64-67%, not quantified in 61%, 33%, and 23-28%, and noted as average incidence without timeline in 8%, 22%, and 6-8%, respectively. In only 3-8% were post-radiotherapy SE quantified with timeline. Specialty concordance (but not tumor risk) was associated with higher granularity of communication, though physicians frequently failed to quantify specialty-concordant SE.
SE was often omitted, not quantified, and/or lacked a timeline in treatment consultations in our sample. Physicians should articulate, quantify, and assign a timeline for SE to optimize SDM.
Prostate cancer and prostatic diseases. 2024 Feb 23 [Epub ahead of print]
Timothy J Daskivich, Aurash Naser-Tavakolian, Rebecca Gale, Michael Luu, Nadine Friedrich, Abhi Venkataramana, Dmitry Khodyakov, Edwin Posadas, Howard Sandler, Brennan Spiegel, Stephen J Freedland
Department of Urology, Cedars-Sinai Medical Center, Los Angeles, CA, USA. ., Department of Urology, Cedars-Sinai Medical Center, Los Angeles, CA, USA., Cedars-Sinai Center for Outcomes Research and Education (CS-CORE), Cedars-Sinai Medical Center, Los Angeles, CA, USA., Department of Biostatistics, Cedars-Sinai Medical Center, Los Angeles, CA, USA., Institute of Urology, University of Southern California, Los Angeles, CA, USA., RAND Institute, Santa Monica, CA, USA., Department of Medicine, Division of Medical Oncology, Cedars-Sinai Medical Center, Los Angeles, CA, USA., Department of Radiation Oncology, Cedars-Sinai Medical Center, Los Angeles, CA, USA.